Carefusion Corp. (CFN) 24.48 -0.52

CareFusion Corporation
(CFN) 24.48 -0.52

Last Trade:	24.46	Day Range:	24.40 - 24.79
Trade Time:	04:05PM	52wk Range:	22.01 - 28.26
Prev. Close:	24.98	Market Cap:	5.43B
Open:	24.67	Div Yield:	0
Volume:	827210	PE:	150
EPS:	1.59

The Latest On CFN

Benzinga's M&A Chatter for Monday April 23, 2012 4/23/12 5:32pm

CareFusion to Sell Neurodiagnostic Business to Natus Medical for $58M 4/23/12 7:07am

CareFusion Announces 510(k) Clearance and U.S. Launch of New Advanced Electrodiagnostic System 3/20/12 8:31am

UPDATE: Goldman Sachs Raises Target to $28 on Carefusion 3/9/12 10:33am

CareFusion To Acquire Pharmacy Automation Technology Leader; Terms Not Disclosed 3/6/12 9:30am

Notable Call Options Activity in CareFusion 2/10/12 4:15pm

CareFusion Announces $500 Million Share Repurchase Program 2/10/12 9:30am

CareFusion and Fisher & Paykel Healthcare Renew Exclusive Distribution Agreement for U.S. Hospital Market 2/8/12 3:31pm

UPDATE: JP Morgan Cuts Target on CareFusion to $29 2/3/12 10:05am

UPDATE: Citigroup Reduces PT to $28 on CareFusion, Reiterates Buy 1/24/12 7:55am

CareFusion Provides Update on Voluntary Recall of Neurological Monitoring Software and Devices 1/20/12 9:31am

CareFusion Issues Q2 Forecast; Shares Down In Pre-Market 1/9/12 9:26am

Benzinga's M&A Chatter for Monday April 23, 2012 4/23/12

CareFusion to Sell Neurodiagnostic Business to Natus Medical for $58M 4/23/12

CareFusion Announces 510(k) Clearance and U.S. Launch of New Advanced Electrodiagnostic System 3/20/12

UPDATE: Goldman Sachs Raises Target to $28 on Carefusion 3/9/12

CareFusion To Acquire Pharmacy Automation Technology Leader; Terms Not Disclosed 3/6/12

Notable Call Options Activity in CareFusion 2/10/12

CareFusion Announces $500 Million Share Repurchase Program 2/10/12

CareFusion and Fisher & Paykel Healthcare Renew Exclusive Distribution Agreement for U.S. Hospital Market 2/8/12

UPDATE: JP Morgan Cuts Target on CareFusion to $29 2/3/12

UPDATE: Citigroup Reduces PT to $28 on CareFusion, Reiterates Buy 1/24/12

CareFusion Provides Update on Voluntary Recall of Neurological Monitoring Software and Devices 1/20/12

CareFusion Issues Q2 Forecast; Shares Down In Pre-Market 1/9/12

Benzinga's M&A Chatter for Monday April 23, 2012 4/23/12

Fast Money Picks For November 3rd (GLD, AUY, BP, EEM, SPY, CFN, CF) 11/2/11

Fast Money Picks For November 2nd (XRT, HGSI, AKS, CFN) 11/1/11

Earnings Preview: Cerner's EPS, Revenue Expected to Rise 10/24/11

Earnings Preview: Baxter International's EPS, Revenue Expected to Rise 10/17/11

Fast Money Picks For September 30th (TBT, HP, CFN, KGC) 9/29/11

Earnings Expectations for the Week of August 8 8/7/11

Earnings Preview: Cerner EPS, Revenue Expected to Rise from Previous Quarter 7/25/11

Thermo Fisher Scientific Earnings Preview: Analyts Expect Higher Earnings, Revenue from Prior Quarter 7/22/11

Calls Purchased on CareFusion Corporation (CFN) 5/6/11

Earnings Preview For Cardinal Health (CAH, CFN, OMI) 4/27/11

Fast Money Picks For January 28th (ABX, SVVS, CFN, LTD) 1/27/11

UPDATE: Goldman Sachs Raises Target to $28 on Carefusion 3/9/12

UPDATE: JP Morgan Cuts Target on CareFusion to $29 2/3/12

UPDATE: Citigroup Reduces PT to $28 on CareFusion, Reiterates Buy 1/24/12

End-of-Day Market Summary for January 5, 2012 1/5/12

BMO Capital Markets Upgrades CareFusion to Outperform 1/5/12

Morgan Keegan Initiates CareFusion at Market Perform 12/14/11

Morgan Keegan Initiates CareFusion Coverage: Market Perform, $28 PT 12/13/11

Bank of America Upgrades CareFusion to Buy, PO Lowered to $28 10/11/11

Morgan Stanley Reiterates Overweight on CareFusion 8/9/11

Bank of America Provides Color on CareFusion 7/26/11

J.P. Morgan Comments On CareFusion Meetings 7/5/11

J.P. Morgan Maintains Overweight on CareFusion 6/20/11

Trade CFN
NOW!

Partner Headlines

Omnicell Completes MTS Acquisition - Analyst Blog 5/29/12

ResMed Debuts in Japan - Analyst Blog 5/24/12

Early Research Calls 5/24/12

Candlesticks - Bearish Engulfing CareFusion 5/24/12

Omnicell Maintained at Neutral - Analyst Blog 5/22/12

ResMed Initiates Dividend - Analyst Blog 5/21/12

New Analyst Coverage 5/17/12

Omnicell Beats, Eyes MTS Medication - Analyst Blog 5/3/12

CareFusion: Is It Still Cheap? (CFN, CAH, BDX, BCR) 5/3/12

ResMed Posts Encouraging 3Q - Analyst Blog 4/27/12

New Ratings ( ISRG, MASI, BDX, CFN ) 4/25/12

Diamond Hill Capital Sees Value in Comcast, VF, CareFusion and Staples 4/20/12

Press Releases

MaxPlus® Clear Needleless Connector Takes Top Market Position 5/3/12 Newswire

CareFusion Reports Third Quarter Fiscal 2012 Results 5/3/12 Newswire

CareFusion to Sell Neurodiagnostic Business to Natus Medical for $58 Million 4/23/12 Newswire

CareFusion and Cerner Integrate Smart Pump Technologies to Help Improve Medication Safety and Efficiency 4/19/12 Newswire

CareFusion Will Host an Earnings Conference Call on May 3 to Discuss the Results for the Third Quarter Fiscal 2012 4/2/12 Newswire

CareFusion Showcases Solutions to Improve Operating Room Effectiveness at Association of periOperative Registered Nurses Congress 3/23/12 Newswire

CareFusion Announces New Take-Apart Line of Laparoscopic Surgical Instruments 3/22/12 Newswire

CareFusion Announces 510(k) Clearance and U.S. Launch of New Advanced Electrodiagnostic System 3/20/12 Newswire

CareFusion To Acquire Pharmacy Automation Technology Leader 3/6/12 Newswire

CareFusion Announces New Technologies To Advance Interoperability With Health Care Information Systems 2/21/12 Newswire

CareFusion Announces $500 Million Share Repurchase Program 2/10/12 Newswire

CareFusion and Fisher & Paykel Healthcare Renew Exclusive Distribution Agreement for U.S. Hospital Market 2/8/12 Newswire

Get the latest CFN stock news on the web. Get the latest stock quotes and much more - Benzinga is the source for CareFusion Corporation stock price.

CareFusion Corporation by YCharts

Carefusion Corp. (CFN) 24.48 -0.52

Quotes

Analysis

Twitter

Ownership

Earnings

The Latest On CFN

From Benzinga's Newsdesk

Benzinga's News Delivered Free

Latest from Premium

Brain Trust

Popular Channels

Tools & Features

About Benzinga

Social